---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-023989"
form_type: "8-K"
ticker: null
cik: "0000859737"
company_name: "HOLOGIC INC"
filed_at: "2024-05-02T23:59:59+00:00"
generated_at: "2026-06-03T01:19:50.214006+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Hologic beats Q2 guidance; raises FY2024 revenue & EPS outlook; acquires Endomagnetics for $310M

## Summary
- Revenue $1,017.8M (-0.8% YoY); GAAP EPS $0.72, Non-GAAP EPS $1.03, both above guidance.
- Organic revenue ex-COVID grew 4.9% constant currency; Diagnostics ex-COVID +9.8%, Surgical +7.7%.
- Raised FY2024 revenue midpoint (constant currency) and EPS guidance on strong margins.
- Agreed to acquire Endomagnetics Ltd for ~$310M to expand interventional breast business.
- Operating cash flow $292.4M in Q2; cash flow from operations remains strong.

## SEC filing metadata
- accession: 0001140361-24-023989
- form_type: 8-K
- cik: 0000859737
- company_name: HOLOGIC INC
- filed_at: 2024-05-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/859737/000114036124023989/0001140361-24-023989-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/859737/000114036124023989/ef20028283_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-023989
- JSON: https://secwatch.observer/filing/0001140361-24-023989.json
- Plain text: https://secwatch.observer/filing/0001140361-24-023989.txt

## Key facts
- Earnings Releases
  HOLOGIC INC reported fiscal second quarter ended March 30, 2024 results: revenue $1,017.8 million, EPS GAAP Diluted EPS of $0.72, and Non-GAAP Diluted EPS of $1.03. Guidance raised.
  - Period: fiscal second quarter ended March 30, 2024
  - Revenue: $1,017.8 million
  - EPS: GAAP Diluted EPS of $0.72, and Non-GAAP Diluted EPS of $1.03
  - Guidance: raised
  - Result: reported results
  source text: Hologic Announces Financial Results for Second Quarter of Fiscal 2024 – Revenue of $1,017.8 Million, GAAP Diluted EPS of $0.72, and Non-GAAP Diluted EPS of $1.03
  evidence_url: https://www.sec.gov/Archives/edgar/data/859737/000114036124023989/0001140361-24-023989-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.